UConn, KeraFast Partner on Stem Cell Lines | GenomeWeb

NEW YORK (GenomeWeb News) – The University of Connecticut has inked a partnership with KeraFast to make stem cells developed at the university available globally.

KeraFast will market two stem cells lines created in 2009 from skin cells taken from patients with deletions of sections of chromosome 15 who develop Angelman Syndrome and Prader-Willi Syndrome. The stem cell lines were developed in the laboratories of UConn researchers Stormy Chamberlain and Marc Lalande.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.